CochLear (OTCMKTS:CHEOY) Downgraded by Zacks Research to Strong Sell

CochLear (OTCMKTS:CHEOY) was downgraded by stock analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Monday,Zacks.com reports.

Separately, UBS Group lowered shares of CochLear from a “strong-buy” rating to a “hold” rating in a report on Thursday, April 23rd. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.

CochLear Stock Up 3.0%

Shares of CHEOY opened at $37.83 on Monday. CochLear has a 1-year low of $31.82 and a 1-year high of $105.60. The firm’s 50 day simple moving average is $41.45 and its 200 day simple moving average is $66.16.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.